Answers are grounded in this paper and cite their sources.
Experimental Approach Demonstrates Sevoflurane's Protective Effects in Rat Testicular Injury, Highlighting New Treatment Options.
Background and Purpose Testicular torsion, a urological emergency, can lead to testicular dysfunction or infertility due to ischaemia–reperfusion injury, yet current interventions remain limited. Although sevoflurane, an inhaled anaesthetic, has shown organ‐protective effects against ischaemia–reperfusion injury in the heart and brain, its role in testicular ischaemia–reperfusion injury is unclear. Experimental Approach A rat model of acute (720° with 3‐h ischaemia/3‐h reperfusion) and long‐term (720° with 1‐h ischaemia/3‐day reperfusion) testicular ischaemia–reperfusion injury was set up to explore the protective effects and mechanisms of preconditioning and post‐conditioning with sevoflurane. Key Results 1.5 minimum alveolar concentration (MAC) sevoflurane for 30 min significantly mitigated acute ischaemia–reperfusion injury, as shown by reductions in bilateral testicular oedema, oxidative stress (lower MDA levels), inflammation (decreased TNF‐α, IL‐6) and apoptosis (reduced Bax/Bcl‐2 ratio). Long‐term, it alleviated testicular atrophy and enhanced sperm count, motility and spermatogenesis. Mechanistically, sevoflurane activated ERK1/2 phosphorylation in the RISK pathway, with its protective effects being abolished by the ERK1/2 inhibitor U0126. Conclusion and Implications Sevoflurane exerts acute and chronic protective effects against bilateral testicular ischaemia–reperfusion injury via ERK1/2 signalling and offers a novel pharmacological strategy to mitigate complications following de‐torsion.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: